STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
32 hedge funds and large institutions have $264M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 10 closing their positions.
Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
17
Increased
7
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$5.96M |
2 |
2
BlackRock
New York
|
$3.22M |
3 |
![]()
3
Adage Capital Partners
Boston,
Massachusetts
|
$13.7M |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$1.27M |
5 |
5
Citadel Advisors
Miami,
Florida
|
$20M |